Additionally, enrichment analysis revealed that SLC16A4 was associated with several cancer-related signaling pathways (Figure 13C,D), including drug metabolism cytochrome P450 (NES = 2.384), cell cycle (NES = −2.706), and mismatch repair (NES = −2.282). The gene discussed is SLC16A4; the disease is cancer.